APG Asset Management US’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-26,664
Closed -$2.53M 126
2025
Q3
$2.53M Hold
26,664
0.02% 95
2025
Q2
$2.37M Buy
+26,664
New +$2.26M 0.02% 93
2024
Q3
Sell
-139,102
Closed -$10.7M 177
2024
Q2
$10.7M Sell
139,102
-71,966
-34% -$5.9M 0.06% 122
2024
Q1
$18.4M Buy
211,068
+22,546
+12% +$1.92M 0.11% 100
2023
Q4
$15.5M Buy
+188,522
New +$14.4M 0.1% 86

Other funds holding MDT

APG Asset Management US's MDT Position: Q4 2025 in Review

APG Asset Management US sold out of Medtronic (MDT) in Q4 2025, closing a stake of 26,664 shares — an estimated $2.53M sold.

APG Asset Management US first reported a position in MDT in Q4 2023 and held it in 5 quarters. The position peaked at $18.4M in Q1 2024. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • APG Asset Management US reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • APG Asset Management US sold 26,664 Medtronic shares in Q4 2025, an estimated $2.53M.
  • APG Asset Management US first reported a position in Medtronic in Q4 2023 and held it in 5 quarters.
  • APG Asset Management US's Medtronic position peaked at $18.4M in Q1 2024.
  • 2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on APG Asset Management US's 13F filing for Q4 2025, filed 12 Feb 2026.